↓ Skip to main content

Utilizing buprenorphine–naloxone to treat illicit and prescription-opioid dependence

Overview of attention for article published in Neuropsychiatric Disease and Treatment, April 2014
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (93rd percentile)
  • High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

blogs
1 blog
twitter
20 tweeters
facebook
1 Facebook page

Citations

dimensions_citation
26 Dimensions

Readers on

mendeley
60 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Utilizing buprenorphine–naloxone to treat illicit and prescription-opioid dependence
Published in
Neuropsychiatric Disease and Treatment, April 2014
DOI 10.2147/ndt.s39692
Pubmed ID
Authors

Ronald Fraser, Sofie Mauger, Kathryn Gill

Twitter Demographics

The data shown below were collected from the profiles of 20 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 60 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 2%
United States 1 2%
Canada 1 2%
Unknown 57 95%

Demographic breakdown

Readers by professional status Count As %
Student > Master 9 15%
Researcher 9 15%
Student > Postgraduate 8 13%
Student > Doctoral Student 7 12%
Student > Bachelor 7 12%
Other 14 23%
Unknown 6 10%
Readers by discipline Count As %
Medicine and Dentistry 34 57%
Psychology 6 10%
Pharmacology, Toxicology and Pharmaceutical Science 2 3%
Nursing and Health Professions 2 3%
Economics, Econometrics and Finance 2 3%
Other 6 10%
Unknown 8 13%

Attention Score in Context

This research output has an Altmetric Attention Score of 22. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 October 2017.
All research outputs
#615,128
of 12,426,906 outputs
Outputs from Neuropsychiatric Disease and Treatment
#81
of 2,103 outputs
Outputs of similar age
#11,908
of 193,199 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#1
of 65 outputs
Altmetric has tracked 12,426,906 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,103 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.6. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 193,199 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 65 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.